Pre-Clinical Vaccine Adjuvant and Therapeutics Manufacturing
Pre-Clinical Vaccine Adjuvant and Therapeutics Manufacturing Analytik reports how its Microfluidizer® processors are enabling researchers develop a range of therapeutic formulations including vaccine adjuvants, liposomes and lipid nanoparticles. By reducing particle size uniformly, Microfluidizers from Analytik are helping a growing number of pharmaceutical companies and Contact Development and Manufacturing Organisations (CDMOs) improve the efficacy, bioavailability, stability and process efficiency of their drugs. Today, Microfluidizer® technology from Analytik is widely viewed as the...